Aktuella utlysningar, vecka 8, 2019

Publicerat 2019-02-20 09:34. Uppdaterat 2019-03-06 15:49This page in English

Grants Office tipsar om aktuella utlysningar

Svenska och nordiska utlysningar

Postdoctoral research grants - Henning and Johan Throne-Holst Foundation

Enable postdoctoral researchers to pursue research within human nutrition and related disciplines at internationally renowned research centres. The grants are cover living, travel and related costs.

Closing date: 1 March 2019

Postdoctoral research grants - Henning and Johan Throne-Holst Foundation 

Doctoral research grants - Henning and Johan Throne-Holst Foundation

Enable PhD students within the field of human nutrition and related disciplines, to visit internationally renowned research centres as part of their training. The grants cover travel, living costs and related costs for a duration of three to 12 months.

Closing date: 1 March 2019

Doctoral research grants - Henning and Johan Throne-Holst Foundation 

Guest researcher grants - Henning and Johan Throne-Holst Foundation

Enable Swedish and Norwegian institutions to host internationally renowned scientists within human nutrition and related disciplines, to strengthen the quality of the research of the hosting institution. Grants cover the visiting scientist’s travel and living costs for a period of one to six months.

Closing date: 1 March 2019

Guest researcher grants - Henning and Johan Throne-Holst Foundation 

SPIRA stipendium - Svenska Sällskapet för Dermatologi och Venereologi

Stöder vårdutvecklande insatser inom psoriasis och hidradenitis suppurativa. Den totala stipendiesumman uppgår till SEK 150,000 och fördelas mellan en till tre stipendiater.

Closing date: 1 March 2019

SPIRA stipendium - Svenska Sällskapet för Dermatologi och Venereologi 

Medel för forskning om funktionshinder - Stiftelsen Svenska Kommittén för Rehabilitering

Stöder vetenskaplig forskning och utredningsverksamhet som syftar till att begränsa verkningarna av rörelsehinder, dövhet, samt hörsel- och synskador. 

Closing date: 1 March 2019

Medel för forskning om funktionshinder - Stiftelsen Svenska Kommittén för Rehabilitering 

Forskningsanslag - Aroseniusfonden

Stöder medicinsk forskning rörande hemofili, von Willebrands sjukdom, andra blödningsrubbningar och genterapi.

Closing date: 8 March 2019

Forskningsanslag - Aroseniusfonden 

Project grants for medicine and health sciences - Swedish Research Council

Enable researchers to conduct a research project related to medicine and health sciences. Grants are worth between SEK 400,000 and SEK 2.5 million per year each for a duration of one to five years.

Closing date: 19 March 2019

Project grants for medicine and health sciences - Swedish Research Council 

Grant for half-time research position in a clinical environment - Swedish Research Council

Enables clinically active persons to conduct research on a half-time basis in parallel with developing their clinical skills. Grants are worth up to SEK 1.85 million each per year for up to three years, with the possibility of a three year extension.

Closing date: 19 March 2019

Grant for half-time research position in a clinical environment - Swedish Research Council 

Project grants for the development of methods for the replacement, reduction and refinement of animal testing - Swedish Research Council

Support projects that promote the development of methods for the replacement, reduction and refinement of animal experiments. Grants are worth between SEK 400,000 and SEK 800,000 per year for up to three years and cover any general operating costs.

Closing date: 19 March 2019

Project grants for the development of methods for the replacement, reduction and refinement of animal testing - Swedish Research Council 

Starting grant within medicine and health Swedish Research Council

Enables junior researchers to establish themselves as independent researchers in Sweden. Grants are worth up to SEK 1.5 million each per year for up to four years.

Closing date: 19 March 2019

Starting grant within medicine and health Swedish Research Council 

Research environment grant within natural and engineering sciences Swedish Research Council

Support interdisciplinary collaboration projects within natural and engineering sciences. Nine grants worth between SEK 2 million and SEK 3m per year for up to six years are available.

Closing date: 19 March 2019

Research environment grant within natural and engineering sciences Swedish Research Council 

Europeiska utlysningar

Research grants on Down’s syndrome - Jérôme Lejeune Foundation

The Jérôme Lejeune Foundation invites applications for its research grants. These support research projects on Down’s syndrome and other rare intellectual disabilities with a genetic origin. The aim is to uncover the pathophysiology of the cognitive deficits of patients, especially those with Down’s syndrome and linked pathologies as well as knowledge of the chromosome 21. Applications may cover fundamental, translational, epidemiological, clinical research, neurobiology and pharmacology.

Closing date: 5 March 2019

Research grants on Down’s syndrome - Jérôme Lejeune Foundation 

Swiss Bridge award - Swiss Cancer League

The Swiss Cancer League, in partnership with Swiss Bridge and the Union for International Cancer Control, invites applications for the Swiss Bridge award. This supports cancer research in Europe. The focus topic for this year is immune cell therapy. Researchers holding a PhD or MD and independent position at a hospital, university or research institute in Europe may apply. Applicants should be under the age of 45 years.

Closing date: 30 April 2019

Swiss Bridge award - Swiss Cancer League

Research grants - Cure Parkinson’s Trust

The Cure Parkinson’s Trust invites applications for its research grants. These support laboratory or clinical research projects that have the potential to advance knowledge that might lead to a cure for Parkinson’s disease. Applications must be for research that slows, stops or reverses the disease and translates into clinical phase 2b trials within five years. Projects must not solely focus on symptomatic aspects of Parkinson’s.

Closing date: 24 April and 26 September 2019

Research grants - Cure Parkinson’s Trust

ERC-2019-PoC proof of concept grants - Horizon 2020

The European Commission Horizon 2020: Excellent Science European Research Council invites proposals for its ERC-2019-PoC proof of concept grants. These aim to maximise the value of ERC-funded research by funding further work to verify the innovation potential of ideas arising from ERC funded projects.

All principal investigators in an ERC frontier research project, that is either ongoing or has ended less than 12 months before 1 January 2019, may apply. 

Closing date: 25 April and 19 September 2019

ERC-2019-PoC proof of concept grants - Horizon 2020

Research grants - Velux Foundation

The Velux Foundation invites applications for its research grants. These support innovative projects addressing the effects of daylight on humans and nature, healthy ageing or ophthalmology research. Basic or applied research projects are eligible. Applicants must be permanent employees of a university or other permanent research entity.

Closing date: 30 April 2019

Research grants - Velux Foundation

Amerikanska utlysningar

Federal Funding agencies

Addressing the Role of Violence on HIV Care and Viral Suppression: NIH

This funding opportunity announcement (FOA) invites applications on violence and the HIV care continuum, including: (1) research that will advance understanding of the role of exposure to violence on engagement and retention in HIV care, HIV medication adherence, and viral suppression, and (2) research to develop and test novel interventions to improve HIV care continuum outcomes for individuals who have experienced violence.
Research topics may include, but are not limited to:

  • Research to understand mechanisms and intervention targets
  • Intervention research to improve the HIV continuum of care
  • Implementation science research

Closing date: April 10, 2019, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-MH-20-200 (R01), RFA-MH-20-201 (R21)

Addressing the Role of Violence on HIV Care and Viral Suppression (R01): NIH

Addressing the Role of Violence on HIV Care and Viral Suppression (R21): NIH

Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed): NIH

This funding opportunity announcement (FOA) encourages state-of-the-art, systematic research approaches to elucidate the role of immune system plasticity in health and in the pathogenesis of dental, oral, and craniofacial (DOC) diseases. This FOA encourages applications that will seek to determine mechanisms underlying the ability or inability of the immune system to dynamically maintain its functional role against internal and external perturbations. The expectation is that new knowledge derived from this research will facilitate development of novel, personalized immunomodulatory-based therapies that shift the balance between degenerative and regenerative processes toward regeneration disease management in a patient-specific manner across the lifespan.

Closing date: Standard dates apply, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-19-172 (R01), PAR-19-173 (R21)

Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R01 Clinical Trial Not Allowed): NIH

Achieving Tissue Robustness Through Harnessing Immune System Plasticity (R21 Clinical Trial Not Allowed): NIH

Drug Discovery For Nervous System Disorders: NIH

This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA NIMH and NIA wish to stimulate research in: 1) Identification, design, synthesis, and preclinical testing of compounds of candidate therapeutics; 2) Initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) Later stage lead optimization to improve efficacy and pharmacokinetics; and 4) Initial drug metabolism and pharmacokinetic properties (DMPK). Emphasis will be placed on projects that provide novel approaches for identifying potential therapeutic agents. Applications aimed at the discovery of novel agents for ameliorating, modifying, or correcting potential aberrations in brain signaling are encouraged. Points to consider relevant to this announcement: ● Applications should be relevant to mental illnesses and/or nervous system disorders relevant to aging. ● The main emphasis of projects submitted under this FOA should be on therapeutic discovery rather than target identification or elucidation of disease mechanisms. Specific Areas of Research Interest and further details can be found in the FOA.

Closing date: Standard AIDS dates, by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): PAR-19-147 (R01), PAR-19-146 (R21)

Drug Discovery For Nervous System Disorders (R01): NIH

Drug Discovery For Nervous System Disorders (R21): NIH

 

Foundation

Angelman syndrome grants, Angelman Syndrome Foundation (ASF), US

Highest priority will be given to pilot projects to test new ideas about pathogenesis and therapeutics of Angelman syndrome, translational research and clinical research studies. Of particular interest to the ASF are studies related to communication, behavioral issues and identification of issues and treatments that impact the daily life of people with Angelman syndrome and their families. Researchers from all countries are encouraged to apply.

Closing date: April 15, 2019

Angelman syndrome grants, Angelman Syndrome Foundation (ASF), US 

Länkar